0000950157-24-000181.txt : 20240213 0000950157-24-000181.hdr.sgml : 20240213 20240213111014 ACCESSION NUMBER: 0000950157-24-000181 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240213 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: British American Tobacco p.l.c. CENTRAL INDEX KEY: 0001303523 STANDARD INDUSTRIAL CLASSIFICATION: CIGARETTES [2111] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38159 FILM NUMBER: 24623535 BUSINESS ADDRESS: STREET 1: GLOBE HOUSE STREET 2: 4 TEMPLE PLACE CITY: LONDON STATE: X0 ZIP: WC2R 2PG BUSINESS PHONE: 44-207-845-2000 MAIL ADDRESS: STREET 1: GLOBE HOUSE STREET 2: 4 TEMPLE PLACE CITY: LONDON STATE: X0 ZIP: WC2R 2PG 6-K 1 form6-k.htm CURRENT REPORT


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 
FORM 6-K
 
 
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
 
February 13, 2024
 
Commission File Number: 001-38159

 
BRITISH AMERICAN TOBACCO P.L.C.
(Translation of registrant’s name into English)

 
Globe House
4 Temple Place
London WC2R 2PG
United Kingdom
(Address of principal executive office)

 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F ☒              Form 40-F ☐
 
 
 
 
 
This report includes materials as exhibits that have been published and made available by British American Tobacco p.l.c. as of February 13, 2024.


EXHIBIT INDEX
 
Exhibit
 
Description
 


  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
British American Tobacco p.l.c.
  
   
 
       
 
By:
/s/ Claire Dhokia
  
    Name: 
Claire Dhokia  
    Title:   
Deputy Company Secretary
  
       
 
Date:  February 13, 2024







 EX-1 2 ex-1.htm PRESS RELEASE

Exhibit 1

Publication of Supplementary Prospectus

The following Supplementary Prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Supplementary Prospectus dated 13 February 2024 (the “Supplementary Prospectus”) relating to the £25,000,000,000 Euro Medium Term Note Programme of B.A.T. International Finance p.l.c., B.A.T Capital Corporation and B.A.T. Netherlands Finance B.V. (as Issuers) and British American Tobacco p.l.c. and each of the Issuers (except where it is the relevant Issuer) (as Guarantors).

The Supplementary Prospectus should be read and construed in conjunction with the Base Prospectus dated 14 March 2023, as supplemented by the supplementary prospectus dated 3 August 2023 (together, the “Prospectus”).

To view the Supplementary Prospectus, and the documents incorporated by reference therein, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/9753C_3-2024-2-13.pdf

https://www.rns-pdf.londonstockexchange.com/rns/9753C_1-2024-2-13.pdf

http://www.rns-pdf.londonstockexchange.com/rns/9753C_2-2024-2-13.pdf

The full documents will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.


Enquiries

British American Tobacco Press Office
+44 (0)20 7845 2888 (24 hours) │@BATPlc


British American Tobacco Investor Relations
Victoria Buxton / Amy Chamberlain / John Harney / Jane Henderson
+44 (0)20 7845 2012 / 1124 / 1263 / 1117


British American Tobacco p.l.c.
Globe House
4 Temple Place
London WC2R 2PG

DISCLAIMER – INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.